Cecilia Low Wang, endocrinologist at UCHealth and professor at University of Colorado School of Medicine, tells TODAY.com
Long-term effectiveness data over a 1-year follow-up period are a key strength of the study, given the relatively recent approval of tirzepatide
Understanding these differences provides an important foundation for comparing how peptides and steroids work, their potential benefits, associated risks, expected timelines for results, and overall treatment costs
If you have kidney or heart limits, ask your clinician first
If your primary health goals are metabolic, including insulin sensitivity, liver health, and body composition rather than specifically cardiovascular, retatrutide broader mechanism of action may deliver more comprehensive benefits